Interestingly, in addition to inhibiting gluconeogenesis and improving peripheral insulin resistance, metformin may exert antioxidant effects through multiple pathways such as reducing inflammatory factor expression, upregulating antioxidant enzymes or downregulating NADPH oxidase,[24] which is consistent with our experimental results (Figure 5F–J). The gene discussed is FMO5; the disease is Insulin resistance.